Omnicare Inc. agreed to pay $28.125 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the prescription drug, Depakote, for nursing home patients.

If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.

Parent company note:

Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.

Note: our penalty amounts include not only fines and monetary settlements but also costs such as supplementary environmental projects or consumer relief that companies are often compelled to undertake as part of settlements. If the settlement includes fines paid to state governments, those are included as well.